India's IPO market soars, but mega deals aren't always safe bets—research before investing in the next big IPO.

Forget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns and offers more than 300,000 other ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

After a record 2025 with 373 listings raising ₹1.95 trillion, primary market activity slows sharply as subscriptions moderate, small- and mid-cap weakness weighs on sentiment, and analysts flag a ...

Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...

In pushing ahead with its IPO, both Medline and investors that are supporting the deal upfront are looking past the negative impact of tariffs. Only 16% of Medline’s total cost of goods sold is ...